11/20
08:30 am
celu
Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
Low
Report
Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
11/18
08:35 am
celu
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter [Yahoo! Finance]
High
Report
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter [Yahoo! Finance]
11/18
08:30 am
celu
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
High
Report
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
11/7
08:00 am
celu
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
High
Report
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
10/23
08:30 am
celu
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel
Medium
Report
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel
10/22
08:30 am
celu
Celularity Provides Corporate Update
Low
Report
Celularity Provides Corporate Update
10/18
06:00 pm
celu
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
High
Report
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
10/16
05:49 pm
celu
Celularity acquires Rebound product from Sequence Lifescience [Seeking Alpha]
Medium
Report
Celularity acquires Rebound product from Sequence Lifescience [Seeking Alpha]
10/16
05:21 pm
celu
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. [Yahoo! Finance]
High
Report
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. [Yahoo! Finance]
10/16
05:15 pm
celu
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.
Medium
Report
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.
9/18
05:39 pm
celu
Amniotic Membrane Market to Grow by USD 2.7 Billion (2024-2028) with AI Impact Boosting Trends in Ophthalmic Surgery Use - Technavio Report [Yahoo! Finance]
Medium
Report
Amniotic Membrane Market to Grow by USD 2.7 Billion (2024-2028) with AI Impact Boosting Trends in Ophthalmic Surgery Use - Technavio Report [Yahoo! Finance]
9/5
04:05 pm
celu
Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
Low
Report
Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
8/28
05:00 pm
celu
Celularity Appoints Richard J. Berman to its Board of Directors [Yahoo! Finance]
Medium
Report
Celularity Appoints Richard J. Berman to its Board of Directors [Yahoo! Finance]
8/28
04:45 pm
celu
Celularity Appoints Richard J. Berman to its Board of Directors
Medium
Report
Celularity Appoints Richard J. Berman to its Board of Directors
8/23
05:00 pm
celu
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Medium
Report
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing